Search
for
Sort by
Research 211–240 of 1000+
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Folliculitis
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Premature graying of hair
- Overview of Facial Plastic Surgery and Current Developments
- A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia
- Hair and scalp disorders in women of African descent: an overview
- What is the Rationale for Androgen Therapy for Women?
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Common Dermatologic Conditions
- Disease progression of dermatophytic pseudomycetoma in a Persian cat
- The Safety of Testosterone Therapy in Women
- Multiple minute digitate hyperkeratosis
- Focal and Generalized Alopecia
- Types and Treatment of Hair Loss in Men and Women
- Testosterone Treatment in Women – An Overview
- Nutritional Clinical Studies in Dermatology
- Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
- Menopause
- Premature Greying of Hair (Premature Canities): A Concern for Parent and Child
- Current and future pharmacotherapy for alopecia areata
- Hair and Scalp Disorders in Women of African Descent
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Scarring Alopecia
- Hair Disorders
- Cutaneous drug reactions
- Aesthetic medicine treatments for oncology patients — a narrative literature review
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial